InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-56.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Worland Stephen T, Chairman & CEO. Director active across 1 company, notably eFFECTOR Therapeutics, Inc.. Aggregated, 8 disclosures have been logged. Breakdown: 1 buy · 0 sell. Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Worland Stephen T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
1,806 shares@ €1.54555.0% of flowCommon StockSEC:0000950170-24-061593:0
5,979 shares@ €0.45714.9% of flowCommon StockSEC:0001209191-23-055557:0
33,799 shares@ €0.473528.9% of flowCommon StockSEC:0001209191-23-045499:0
6,401 shares@ €0.42214.9% of flowCommon StockSEC:0001209191-23-029646:0
6,047 shares@ €0.45395.0% of flowCommon StockSEC:0001209191-22-057379:0
20,000 shares@ €1.2805100.0% of flowCommon StockSEC:0001209191-22-035277:0
Canonical exit: 5 Sept 2022 (T+90)
1,837 shares@ €1.4749.6% of flowCommon StockSEC:0001209191-22-029890:0
512,339 sharesCommon StockSEC:0001209191-21-053686:0
8 of 8 declarations
About Worland Stephen T
WORLAND STEPHEN T is Président-Directeur Général and Chief Executive Officer at eFFECTOR Therapeutics, Inc. The record shows 8 filings, with activity captured in the recent filings tracked from 2021-08-27 to 2024-05-17, and the most frequent transaction nature is Attribution.
